English
Back
Open Account

Yisheng Biotechnology (01061.HK) 2022 Annual Results Conference

Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty. Read more
1
4
+0
8
See Original
Report
12K Views
Comment
Sign in to view/post comments
avatar
ESSEX BIO-TECH
The official account of Essexbio Bio
A biopharmaceutical company focusing on the research, development, production and sales of the genetically engineered drug rb-bFGF (recombinant bovine basic fibroblast growth factor)
14K
Followers
13K
Visitors
Follow
Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to unsettle the stock market. However, the latest developments suggest Show More